Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Drugs Public Price List


Lebanon National Drugs Database

 
Drugs Prices According to the Exchange Rate Issued on 5/2/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
16/7/2024 89,500 LBP Drugs Public Price List
13/6/2024 89,500 LBP Drugs Public Price List
27/5/2024 89,500 LBP Drugs Public Price List
14/5/2024 89,500 LBP Drugs Public Price List
17/4/2024 89,500 LBP Drugs Public Price List
21/3/2024 89,500 LBP Drugs Public Price List
20/3/2024 89,500 LBP Drugs Public Price List
7/3/2024 89,500 LBP Drugs Public Price List
12/2/2024 90,000 LBP Drugs Public Price List
5/2/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
16/7/2024 Non subsidized Drugs List
13/6/2024 Non subsidized Drugs List
14/5/2024 Non subsidized Drugs List
17/4/2024 Non subsidized Drugs List
21/3/2024 Non subsidized Drugs List
20/3/2024 Non subsidized Drugs List
7/3/2024 Non subsidized Drugs List
12/2/2024 Non subsidized Drugs List
5/2/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
16/7/2024 89,500 LBP List of medicines covered by Resolution 945/1
13/6/2024 89,500 LBP List of medicines covered by Resolution 945/1
27/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
14/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
17/4/2024 89,500 LBP List of medicines covered by Resolution 945/1
21/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
20/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
7/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
12/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
5/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 
Drugs Prices According to the Exchange Rate Issued on 10/1/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
10/1/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
15/1/2024 Addendum: Non subsidized Drugs List
10/1/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
10/1/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 

Drugs Prices Reduction
Lists of Drugs Prices Reduced From 2015 until 2019
 
    2
ATC Name B/G Ingredients Dosage Form Price
B02BD06 HAEMATE P BioHuman Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU Injectable lyophilised powder for solution+diluent 32,710,519 L.L
B02BB01 HAEMOCOMPLETTAN P BioHuman Fibrinogen, human - 1g 1g Injectable powder for solution 38,763,115 L.L
B02BB01 HAEMOCOMPLETTAN P BioHuman Fibrinogen, human - 2g 2g Injectable powder for solution 77,527,404 L.L
B05AA01 HUMAN ALBUMIN "OCTAPHARMA" 20% BioHuman Albumin human - 20% 20% Injectable solution 4,863,366 L.L
B05AA01 HUMAN ALBUMIN 20% SOLUTION BioHuman Albumin human - 20% 20% Injectable solution 4,055,430 L.L
B05AA01 HUMAN ALBUMIN BEHRING 20%, LOW SALT BioHuman Albumin human - 20% 20% Injectable solution 4,055,430 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 26,715,144 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 26,715,144 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 60mg/0.4ml 60mg/0.4ml Injectable solution 7,234,169 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution 3,683,752 L.L
A10AB01 HUMULIN R U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 701,486 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 150mg/ml 150mg/ml Injectable solution 14,689,154 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 105mg/0.7ml 105mg/0.7ml Injectable solution 11,845,462 L.L
A10AB04 HUMALOG KWIKPEN BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable solution 4,542,188 L.L
A10AB04 HUMALOG BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable suspension 2,411,838 L.L
A10AB04 HUMALOG KWIKPEN BioTech Insulin lispro - 200IU/ml 200IU/ml Injectable solution 8,585,913 L.L
A10AD01 HUMULIN 70/30 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose 0.5ml/dose Injectable suspension 1,777,904 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose 0.5ml/dose Injectable suspension 2,257,655 L.L
A10AD04 HUMALOG MIX 50 KWIKPEN BioTech Insulin lispro solution - 50%, Insulin lispro protamine suspension - 50% 100IU/ml Injectable suspension 4,542,188 L.L
A10AD04 HUMALOG MIX 25 KWIKPEN BioTech Insulin lispro solution - 25%, Insulin lispro protamine suspension - 75% 100IU/ml Injectable suspension 4,542,188 L.L
A10AE01 HUMULIN N U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,509,935 L.L
H01AC01 HHT BioTech Somatropin recombinant - 16IU (5.32mg) 16IU (5.32mg) Injectable freeze dried powder + diluent 4,078,562 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 14,127,375 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 940,690 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 10,000IU 10,000IU Injectable freeze dried substance+diluent 2,490,140 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 20,000IU 20,000IU Injectable freeze dried powder + diluent 5,438,531 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 40,000IU 40,000IU Injectable freeze dried powder + diluent 6,316,060 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution 89,170,219 L.L
    2
Sitemap
© Copyrights reserved to Ministry of Public Health 2024